ASCO 2019: Suggested benefit in PCV chemoradiotherapy for both IDH-mutant WHO-defined molecular subgroups
A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase…
A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase…